Larcomb v. Smith

CourtDistrict Court, D. Maryland
DecidedOctober 6, 2022
Docket1:21-cv-02759
StatusUnknown

This text of Larcomb v. Smith (Larcomb v. Smith) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Larcomb v. Smith, (D. Md. 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MARYLAND Southern Division

DOUGLAS LARCOMB, *

Plaintiff, *

v. * Civil Action No. GJH-21-2759

J. CHARLES SMITH, III, et al., *

Defendants. * *** MEMORANDUM OPINION

Plaintiff Douglas Larcomb, a prisoner currently confined at Maryland Correctional Training Center (“MCTC”), brings this civil rights action against Defendants J. Charles Smith, III; Frederick County, Maryland; the State of Maryland; and the United States of America concerning his detention at the Frederick County Adult Detention Center (“FCADC”). ECF No. 1. In his initial complaint he alleged that he was denied bail1 and has “aggressive cancer” that has not been treated for “over 200 days.” ECF No. 1 at 3.2 The initial complaint sought only injunctive relief. Id. Given the serious nature of Plaintiff’s allegation concerning his medical care, which potentially impacted his safety and well-being, and in light of the fact that Plaintiff was committed to the custody of the Frederick County Sheriff, on November 1, 2021, the Court entered an Order directing the Frederick County Attorney to show cause why relief should not be granted. ECF No. 3. On November 22, 2021, the Order was returned to the Court as

1 Larcomb’s claims regarding his bail status are before the Court in Larcomb v. Smith, et al., Civil Action No. GLR 21-2392 (D. Md.) and will not be considered in the context of this case.

2 The docket numbers and page references are those assigned by the Court’s electronic docket. undeliverable to Plaintiff. ECF No. 4. As such, on December 9, 2021, the Court dismissed the Complaint without prejudice, due to Plaintiff’s failure to apprise the Court of his location. ECF No. 5. On March 9, 2022, Plaintiff filed a Motion to Reopen the case, stating he was detained at FCADC and his medical condition remained unchanged. The Motion to Reopen was granted and

the Frederick County Attorney was directed to show cause why relief should not be granted. ECF No. 8. A response to the Order was filed, which included pertinent portions of Plaintiff’s medical records. ECF No. 12. Defendant Frederick County also filed a Motion to Seal (ECF No. 13), which is not opposed by Plaintiff. Thereafter, on April 27, 2022, Plaintiff filed an Amended Complaint, asserting the same claims regarding bail and lack of medical care, naming the same Defendants, and adding a claim for damages in the amount of a “billion dollars.” ECF No. 14. Defendant Frederick County filed a Motion to Dismiss, or in the Alternative for Summary Judgment (ECF No. 18) and response to the Complaint (ECF No. 20). Due to the inclusion of portions of Plaintiff’s medical records,

Defendants again filed a Motion to Seal (ECF No. 19), which is unopposed by Plaintiff. Plaintiff then filed a number of “Motions,” which the Court generously construes as opposition responses. See e.g., ECF No. 24 (Motion to Review); ECF No. 25 (Motion for Injunctive Relief); ECF No. 26 (Supplement of ECF Nos. 24 and 25); ECF No. 27 (Motion to Enter Into Evidence); ECF No. 29 (Joint Motion to Review and Enter Evidence). Lastly, Plaintiff has advised the Court that he is no longer detained at the FCDAC, but rather is in the custody of the Maryland Department of Corrections housed at MCTC. ECF No. 30. No hearing is necessary to resolve the pending motions. See Loc. R. 105.6 (D. Md. 2021). For the following reasons, Plaintiff’s requests for injunctive relief are denied, Defendant’s Motion to Dismiss or, in the Alternative, for Summary Judgment is denied as moot, Plaintiff’s Motions to Review, for Injunctive Relief, to Supplement, to Enter Into Evidence, and to Review and Enter Evidence are denied, and Defendant’s Motions to Seal are granted.

I. BACKGROUND In his Complaint, as Amended, Plaintiff states that he has been diagnosed with cancer and has been denied treatment while housed at FCADC awaiting trial. ECF Nos. 1 and 14. In October of 2021, while Plaintiff was housed at FCADC awaiting trial, the Circuit Court for Frederick County determined he was incompetent to stand trial and committed him to the Maryland Department of Health. ECF No. 18-2, ¶ 5 (DeLauter Decl.); ECF No. 18-3. Plaintiff was transferred to Springfield Hospital Center on October 29, 2021. ECF No. 18-2, ¶ 6; see also ECF No. 18-4. Plaintiff did not return to FCADC until January of 2022. ECF No. 18-6, ¶ 13.

Shortly after Plaintiff first came into custody at FCADC, staff began gathering information related to his cancer diagnosis and his stated desire to participate in a clinical trial offered by the National Institute of Health (“NIH”)/National Cancer Institute (“NCI”). ECF No. 18-6, ¶¶ 5, 12 (Fernholz Decl.); ECF No. 18-12 at 1. Plaintiff was evaluated by Dr. Keith Wilson, Jr. on April 1, 2021, and the cancer diagnosis was discussed. ECF No. 18-12 at 2. Ms. Fernholz, Health Services Administrator for FCADC, attempted to facilitate Plaintiff’s enrollment in the NIH/NCI clinical study, however, on July 2, 2021, she was informed that Plaintiff could not participate in the trial while incarcerated. ECF No. 18-6 , ¶¶ 6, 7. Fernholz requested written confirmation that Plaintiff was not eligible to participate in the trial (id., ¶ 8; see also ECF No. 18-8) but did not receive the denial in writing. ECF No. 18-6, ¶ 8. On July 6, 2021, in response to Plaintiff’s medical request, Fernholz advised him that NIH/NCI would not allow his participation in the trial. ECF No. 18-2, ¶ 9; ECF No. 18-9. Plaintiff next saw Dr. Wilson on July 8, 2021, and again discussed his cancer diagnosis. ECF No. 18-2 at 2-3.

On September 6 and 7, 2021, Plaintiff filed medical requests, stating that he did not believe NIH/NCI denied his request to participate in the clinical trial. ECF No. 18-6, ¶10. He also requested the contact information for the person who was contacted at NIH/NCI. Id.; ECF No. 18-2; ECF No. 18-10. Fernholz responded to Plaintiff providing him the requested information. Id. Plaintiff was seen by Dr. Wilson on October 17, 2021. ECF No. 18-2, ¶ 11; see also ECF No. 18-11 at 4. Dr. Wilson again discussed with Plaintiff his cancer diagnosis. It was noted that blood work had been ordered and upon its receipt a determination would be made whether Plaintiff required an outside medical consultation. ECF No. 18-11 at 6. However, before

Plaintiff could be brought in for a follow-up visit and his blood work reviewed, he was transferred out of the facility. ECF No. 18-6, ¶ 12; ECF No. 18-4; ECF No. 18-12 at 11. When Plaintiff returned to FCADC in late January 2022, two attempts were made to schedule Plaintiff to be seen by the WellPath physician.3 See ECF No. 18-6, ¶ 13; CF No. 18-12 at 12-13. However, both appointments were marked to be rescheduled. Id. Plaintiff had a complete physical on April 19, 2022. ECF No. 18-6, ¶ 14; ECF No. 18-13. At that time, the order for bloodwork was renewed and a follow-up appointment to discuss chronic issues was to be scheduled. ECF No. 18-6, ¶ 14; ECF No. 18-13 at 5. Ms. Fernholz avers

3 The contract to provide medical services to detainees at FCADC changed from WellPath to NaphCare on April 1, 2022. See ECF No. 12 at 4. that she was advised the follow up appointment would occur sometime in May of 2022, and the results of the tests would be discussed and a treatment protocol set for Plaintiff’s chronic conditions, including his cancer diagnosis. ECF No. 18-6, ¶ 14. On May 5, 2022, Plaintiff met with a NaphCare nurse practitioner (“NP”) to discuss the results of his lab work. The NP noted Plaintiff was not compliant with certain medications and:

Patient not willing to explore any other treatment options for his prostate cancer. He reported that he would only accept treatment options (focal laser ablation and immunotherapy) offered by his doctors at [Johns Hopkins Hospital] and [the National Institute of Health] (Dr. Siddiqi, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Imbler v. Pachtman
424 U.S. 409 (Supreme Court, 1976)
Bell v. Wolfish
441 U.S. 520 (Supreme Court, 1979)
City of Revere v. Massachusetts General Hospital
463 U.S. 239 (Supreme Court, 1983)
Pennhurst State School and Hospital v. Halderman
465 U.S. 89 (Supreme Court, 1984)
Neitzke v. Williams
490 U.S. 319 (Supreme Court, 1989)
Burns v. Reed
500 U.S. 478 (Supreme Court, 1991)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Lyles v. Sparks
79 F.3d 372 (Fourth Circuit, 1996)
McLean v. United States
566 F.3d 391 (Fourth Circuit, 2009)
Baynard v. Malone
268 F.3d 228 (Fourth Circuit, 2001)
Love-Lane v. Martin
355 F.3d 766 (Fourth Circuit, 2004)
Shaw v. Stroud
13 F.3d 791 (Fourth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Larcomb v. Smith, Counsel Stack Legal Research, https://law.counselstack.com/opinion/larcomb-v-smith-mdd-2022.